|Publication number||US20050107740 A1|
|Application number||US 11/017,116|
|Publication date||May 19, 2005|
|Filing date||Dec 20, 2004|
|Priority date||Nov 30, 2001|
|Also published as||CA2468243A1, CA2468243C, CN1294997C, CN1596138A, DE60208933D1, DE60208933T2, DE60230933D1, EP1448256A1, EP1448256B1, EP1557191A2, EP1557191A3, EP1557191B1, US6855129, US7553293, US8728027, US20030120209, US20050065476, US20090227950, US20110021988, US20150038903, WO2003045480A1|
|Publication number||017116, 11017116, US 2005/0107740 A1, US 2005/107740 A1, US 20050107740 A1, US 20050107740A1, US 2005107740 A1, US 2005107740A1, US-A1-20050107740, US-A1-2005107740, US2005/0107740A1, US2005/107740A1, US20050107740 A1, US20050107740A1, US2005107740 A1, US2005107740A1|
|Inventors||Karsten Jensen, Niels Nymark|
|Original Assignee||Karsten Jensen, Niels Nymark|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (17), Referenced by (7), Classifications (18)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation of application Ser. No. 10/307,045 filed on Nov. 29, 2002 and claims the benefit of priority of US provisional application 60/343,045, filed Dec. 22, 2001 and Danish Application PA 2001 01772, filed Nov. 30, 2001, under 35 U.S.C. 119 and U.S. application Ser. No. 10/307,045 filed on Nov. 29, 2002 under 35 U.S.C. 120; the contents of all of which are hereby incorporated by reference in their entirety.
The invention relates to a safety needle assembly, which reduces the risk of accidental needle-stick injuries, and especially a safety needle assembly where a needle cannula is mounted in a hub.
Needle assemblies are commonly used to either inject substances into or extract substances out of human or animal bodies. Such needle assemblies are typically disposable and are discarded after only one use. The problem presented by the disposal of a needle assembly, and indeed, by any handling of the needle assembly, is the potential risk of being injured by the sharp end of the needle cannula. This is particular dangerous when following after the penetration of a patients skin since the needle cannula then may be contaminated and therefore capable of spreading diseases such as hepatitis and HIV.
A great number of safety needle assemblies has been developed where the needle cannula is concealed by a telescopically movable shield during the injection.
One such prior art needle protection system is disclosed in WO 01.76665. This safety needle comprises a hub with a centrally located needle cannula. A telescopically movable shield is provided on the outside surface of the hub. The shield is telescopically movable between a first position where it fully covers the needle cannula and a second position where a part or the needle cannula is left free to perform an injection. A cam element, rotatable mounted to the hub is provided with at least one cam, which cam is guided in cam curve provided in the inside surface of the shield. The shield is urged in the distal direction by a spring cocked between the hub and the shield. The cam curve is adapted to block the cam in a blocking position when the shield returns to the first position after an injection has been performed.
The safety needle assembly disclosed in WO 01.76665 is however rather cumbersome and consist of a large number of parts that must be moulded and afterwards fitted together very precisely in order to obtain the correct movement of the cam follower.
It is also a fact that the different plastic parts of an assembled construction have a tendency to change the relative dimensions when the construction is sterilized using steam or gas. This is especially critical when the tolerances have to be very narrow, as in the safety needle assembly disclosed in WO 01.76665.
In order to assure that the cam element of WO 01.76665 in fact shifts into the locked position when the protective cap moves back to the initiate position after an injection has been made, a rather powerful spring is needed. This is an inconvenience for the user, since the user has to press the protective cap in the proximal direction literally with the use of his or hers skin while making the injection.
It is henceforth an object of the present invention to provide a safety needle assembly, which overcomes the inconveniences of the prior art safety needle assemblies, and especial to provide a safety needle assembly which is made from fewer parts, and which parts are not subject to very strict tolerances.
It is further an objective of the present invention to provide a safety needle assembly having a spring with only a limited force thereby offering the user maximum comfort.
In order to overcome the drawbacks of the prior art it is suggested to provide the safety needle assembly with a separate locking element located between the spring and the shield according to claim 1.
When the locking element is provided as a separate element located between the spring and the shield and moved simultaneously with the shield, the locking protrusion can be guided during the longitudinal movement of the locking member thereby eliminating the need for tracks or cams thus making it possible to construct the safety needle assembly from only three plastic part in addition to the hub.
Since there are no tracks or cams as such the internal tolerances are not that important, and the friction can be kept rather low which renders it possible to utilize a somewhat soft spring, which enhances the user comfort.
By blocking the rotational movement of the locking protrusion with a fin provided on the inside surface of the housing as specified in claim 2, it is possible to define when the rotatable movement of the locking protrusion should commence simply by specifying a specific length of the fin.
Once the locking protrusion on the locking element has passed over the end of the fin as specified in claim 3 it will be impossible to move the locking protrusion backwards. The length of the fins can be made such that once the shield has been activated and the needle cannula has emerged from the opening in the shield it will be impossible to abort the injection and keep the needle for later use.
When the locking protrusion engages the toothed ring of the shield as defined in claim 4, the shield can be moved all the way back in the proximal direction thereby uncovering the needle cannula.
When the injection is over and the locking protrusion is arrested in the opening in the longitudinal rib as mentioned in claim 5, it is virtually impossible to advance the needle cannula again by pressing the shield backwards in the proximal direction.
The guiding means for guiding the locking protrusion comprises only horizontally defined ribs and fins as specified in claim 6. This makes both the moulding of the parts and the assembly of the parts very simple.
By mounting the shield inside the housing as disclosed in claim 7, it is ensured that the shield cannot be separated from the housing.
When the spring cocked between the locking element and the hub interfaces both the locking element and the bottom surface of the housing as revealed in claim 8, it is ensured that the spring can be added to the assembly in a very simple manner.
By providing the housing with a window through which the locking protrusion can be viewed when it is in the arrested position, it is ensured that a user can visible inspect whether the safety needle assembly has been used before or not.
The part of the shield and/or the locking element that are visible through the window when the safety needle assembly is in the unused condition can also be coloured in a colour indicating that the safety needle assembly is ready for use.
The window can either be transparent or simply an opening in the sidewall of the housing.
In the present context, the term “moving simultaneous” which are used to describe the relationship between the movement of the shield and the locking element, does not necessary mean that the shield and the locking protrusion moves with the same speed. The relative speed of movement is defined by the various angled surfaces, and is therefore variable. The term “moving simultaneously” merely means that both the shield and the locking protrusion move at the same time.
The invention will be explained more fully below in connection with a preferred embodiment and with reference to the drawings in which:
The figures are schematic and simplified for clarity, and they just show details, which are essential to the understanding of the invention, while other details are left out. Throughout, the same reference numerals are used for identical or corresponding parts.
Initially it may be convenient to define that, the term “distal end” is meant to refer to the end of the safety needle assembly inserted into the patient, whereas the term “proximal end” is meant to refer to the end connected to the injection device.
The connecting surface 5 between the hub 3 and the body 4 is in the figures shown in a specific position, but could off cause be located as wanted. The hub 3 and the body 4 could even be moulded as one piece closed at the top surface 6 by a lit. The top surface 6 is provided with an opening 8 through which the shield 2 appears.
The shield 2 is provided with a needle outlet 7 through which the needle cannula 30 can penetrate. The proximal end of the shield 2 is, as shown in
The housing 1 has a bottom surface 9 in the centre of which the needle cannula 30 is mounted. The needle cannula 30 can either be mounted such that a part of needle cannula 30 projects from the bottom surface 9 in the proximal direction, which is preferred for use with cartridges, or it can be mounted without this so called back needle, which is preferred for hypodermic syringes. Adjacent the bottom surface 9, at the proximal end of the housing 1, means are provided for mounting the safety needle assembly on to an injection device. These means would normally be a thread 35 such that the safety needle assembly can be screwed onto a pen syringe.
The locking element 16 seen in
The body 4 of the housing 1 is in
Although the embodiment here described has eight studs 10, four locking protrusions 17 and four windows 20, these parts could be provided in a different number, as shown in
When the safety needle assembly shown in
The assembled safety needle assembly is shown in
The shield 2 is located such within the body 4 of the housing 1 that each rib 21 and each fin 22 is located in the space 26 between two studs 10. The upper part 21 a of the ribs 21 are however not shown in
Once the shield 2 and the locking element 16 is correctly mounted within the body 4 of the housing 1, the spring 25 is located around the needle cannula 30 and the body 4 and the hub 3 are sealed together, rendering the safety needle assembly ready for use.
The movement of the locking protrusion 17 is schematically shown in
Once the locking protrusions 17 is moved free of the fins 22, as shown in
When the injection is over, the needle cannula 30 is retracted from the skin of the user, which will cause the shield 2 with the studs 10 and the locking element 16 with the locking protrusion 17 to move in the distal direction due to the impact of the force F executed by the spring 25. The arrow 29 in
At the proximal end of the locking protrusion 17, the planar back front 19 will abut or at least be blocked by the blocking surface 15 on the ribs 21 of the body 4 of the housing 1, thereby rendering it impossible to move the shield 2 in the proximal direction. At the distal end, the angled fore front 18 of the locking protrusion 17 will abut the toothed ring 13 of the shield 2 and since the planar forefront 11 of the studs 10 on the shield 2 abuts the collar 24 of the body 4 of the housing 1 it will not be possible to move the shield 2 in the distal direction. Sideways the studs 10 of the shield 2 will be arrested between the upper part 21 a of the ribs 21 and the fins 22. As a result of this it will be impossible to move the shield 2 in any direction.
Instead of having the angled fore front 18 of the locking protrusion 17 in abutment with the toothed ring 13 of the shield when the injection is over, the front end 36 of the locking element 16 can be design to abut the inner top end 37 of shield 2 once the locking protrusion 17 is in the locking position. This will make it virtually impossible to squeeze the angled fore front 18 of the locking protrusion 17 by pushing the shield 2 in the proximal direction.
The body 4 of the housing 1 is provided with four windows 20 which windows 20 divides each of the four ribs 21 into an upper part 21 a and a lower part 21 b. When the safety needle assembly has been used, the locking protrusion 17 on the locking element 16 will be located between the upper part 21 a and the lower part 21 b of the ribs 21, and will thus be visible through the window 20. The locking protrusion 17, or a part of it, could be coloured in an inflammatory colour, or provided with another indication, which will render it very easy for a user to visibly inspect whether the safety needle assembly has been used or not just by glancing at the windows 20. The windows 20 could e.g. be provided as openings in the wall of the body 4.
Prior to use, the safety needle assembly is delivered to the user sterilized and contained as is shown in
The spring 30 urging the locking element 16 and the shield 2 in the distal direction is preferably made from stainless non-corrosive steel such that the spring 30 will not be damaged during the steam sterilization process. A spring 30 particular suitable for this purpose is a 1.4462/SAF2205 spring.
Another embodiment of the safety needle assembly according to the invention is disclosed in
The shield 43 is provided with four studs 46 and ends at the proximal end in a toothed ring 38.
This toothed ring 38 engages a second toothed ring 39 located on the locking element 44. The locking element 44 is further provided with a locking protrusion 49 located at the proximal end thereof.
The needle cannula 30 is in
The four studs 46 on the shield 43 is guided in first horizontal tracks 51 provided on the inside surface of the housing 40. The locking protrusion 49 on the locking element 44 abuts a planar surface 48 in its initiate position and is guided in a second horizontal track 52 as the shield 43 is moved in the proximal direction. Once the shield 43 has been moved all the way back to its most proximal position and the injection is executed, a not shown spring positioned between the bottom surface 50 and the locking element 44 will urge the locking element 44 and hence the shield 43 in the distal direction. During this movement, the angled fore front 47 of the locking protrusion 49 will engage a diagonal track 53 also provided in the inside surface of the housing 40. While the shield 43 moves back to its initiate position, the locking element 44 and hence the locking protrusion 49 will rotate approximately 180 degrees in the diagonal track 53 and engage a locking chamber 54 provided at the distal end of the diagonal track 53, which locking chamber 54 has a blocking surface 55 that a planar back front 56 of the locking protrusion 49 will abut rendering further movement of the shield 43 impossible. The first toothed ring 38 of the shield 43 and the second toothed ring 39 of the locking element 44 support this movement due to mutual engagement of the angled surfaces of the two rings 38, 39.
The shield 43 cannot be rotated relatively to the housing 40 due to the engagement of the studs 46 with the first horizontal tracks 51. Since rotation of the shield 43 is inhibited it is impossible to rotate the locking protrusion 49 of the locking element 44 backwards in the diagonal track 53, and the locking protrusion 49 will therefore remain in the locking chamber 54 thus rendering the safety needle assembly secured.
A window could be provided in the housing 40 through which window the locking chamber 54 can be viewed, such that the user can get a visible indication whether the safety needle assembly has been used or not.
An improved embodiment of the safety needle assembly disclosed in
In the following the numbers referring to the same element as in the previous figures has been given the same number plus one hundred.
The safety needle assembly shown in
The body 104 is in this embodiment provided with three windows 120 and the locking element 116 is also provided with three locking protrusions 117. When the locking element 116 locks the safety needle assembly from reuse, the three locking protrusions 117 will be visible in the three windows 120 as earlier explained.
The shield 104 which is preferably made from TPX can be transparent such that the tip of needle cannula 130 is visible for inspection by the user prior to injection, has on its proximal end six studs 110. The toothed ring 113 formed between these studs 110 is therefore in this embodiment only provided with six valleys.
The locking element 116 which is preferably made from POM or PP is on the distal end surface provided with a serrated ring 161 which are used during the manufacturing process. When the safety needle assembly is being assembled a tool can enter the safety needle assembly through the needle outlet 107 in the shield 102 and engage this serrated ring 161 in order to rotate the locking element 116 to the correct position before the shield 102 and the locking element 116 is permanently encapsulated in the housing. For this purpose the needle outlet 107 needs to be large enough for the toll to pass through the needle outlet 107.
In the embodiment shown in
When the safety needle assembly is assembled the whole unit is packed in a container 131 which container 131 is sealed with a removable seal 163 and sterilized. The removable seal 163 is preferably made from paper.
The distal part of the container 131 can be formed as a cup 164 holding a predetermined volume as shown in
Some preferred embodiments have been shown in the foregoing, but it should be stressed that the invention is not limited to these, but may be embodied in other ways within the subject matter defined in the following claims.
List of parts:
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4723943 *||Dec 31, 1986||Feb 9, 1988||Montana Deaconess Medical Center||Sheathed syringe|
|US4795432 *||Feb 19, 1987||Jan 3, 1989||Karczmer Claude M||Shield assembly for hypodermic injection devices|
|US4894055 *||Dec 28, 1988||Jan 16, 1990||Sudnak Paul J||Needle guard assembly for use with hypodermic syringes and the like|
|US5197953 *||Jul 8, 1991||Mar 30, 1993||John Colonna||Cap assembly|
|US5292314 *||Feb 11, 1993||Mar 8, 1994||International Medical Consultants, Inc.||Automatic needle protector|
|US5346480 *||Dec 14, 1992||Sep 13, 1994||Q-Med, Inc.||Syringe with retractable needle|
|US5380494 *||Oct 29, 1992||Jan 10, 1995||Sumitomo Chemical Company, Limited||Apparatus for gas phase polymerization and method for operating the same|
|US5403286 *||Nov 12, 1993||Apr 4, 1995||Lockwood, Jr.; Hanford N.||Hypodermic needle safety device with sliding outer cover|
|US5415645 *||Apr 29, 1994||May 16, 1995||Friend; John M.||Retractable sheath for hypodermic needle|
|US5429612 *||Nov 25, 1991||Jul 4, 1995||Dentoptic||Syringe with a slidable needle protection device|
|US5433712 *||Jun 10, 1993||Jul 18, 1995||Donald E. Stiles||Self-sheathing hypodermic syringe|
|US5472430 *||Aug 18, 1993||Dec 5, 1995||Vlv Associates||Protected needle assembly|
|US5486164 *||May 6, 1993||Jan 23, 1996||Showa Hatsumei Kaisha, Ltd.||Passive protector for hypodermic needles|
|US5674203 *||Dec 6, 1995||Oct 7, 1997||Becton, Dickinson And Company||Needle device having safety indication features|
|US5688241 *||Apr 15, 1996||Nov 18, 1997||Asbaghi; Hooman Ali||Automatic non-reusable needle guard|
|US6855129 *||Nov 29, 2002||Feb 15, 2005||Novo Nordisk A/S||Safety needle assembly|
|US20050065476 *||Nov 1, 2004||Mar 24, 2005||Karsten Jensen||Safety needle assembly|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7553293||Nov 1, 2004||Jun 30, 2009||Novo Nordisk A/S||Safety needle assembly|
|US7785296||Jul 17, 2008||Aug 31, 2010||Smiths Medical Asd, Inc.||Needle tip spring protector|
|US8764706||Feb 4, 2010||Jul 1, 2014||Becton, Dickinson And Company||Disposable pen needle with re-use prevention features|
|US9095660||Oct 21, 2011||Aug 4, 2015||Novo Nordisk A/S||Disposable double point injection needle and an insulin injection system comprising a disposable double point injection needle|
|EP2578255A1 *||Oct 6, 2011||Apr 10, 2013||Sanofi-Aventis Deutschland GmbH||Needle safety device|
|WO2010090735A1 *||Feb 4, 2010||Aug 12, 2010||Becton, Dickinson And Company||Disposable pen needle with re-use prevention features|
|WO2013050471A1 *||Oct 4, 2012||Apr 11, 2013||Sanofi-Aventis Deutschland Gmbh||Needle safety device|
|U.S. Classification||604/110, 604/263|
|International Classification||A61M5/00, B42D15/00, G09F1/04, A61M5/32|
|Cooperative Classification||G09F1/04, A61M5/002, A61M2005/3247, A61M5/3271, B42D15/00, A61M2205/6063, A61M2005/3267, A61M5/3245, A61M5/326|
|European Classification||B42D15/00, G09F1/04, A61M5/32C2H2F|